We are live on
!
Find out more
ML
McAdam LLC Portfolio holdings
AUM
$2.22B
1-Year Est. Return
16.98%
This Fund
S&P 500
This Quarter
Est. Return
+6.9%
1 Year Est. Return
+16.98%
3 Year Est. Return
+46.26%
5 Year Est. Return
+42.13%
10 Year Est. Return
–
AUM
$1.56B
AUM Growth
+$173M
(+12%)
Cap. Flow
+$80.8M
Cap. Flow
% of AUM
5.18%
Top 10 Holdings %
Top 10 Hldgs %
59.36%
Holding
315
New
35
Increased
144
Reduced
103
Closed
13
Top Buys
| 1 |
Schwab US Large- Cap ETF
SCHX
|
+$9.78M |
| 2 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$9.7M |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$6.97M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$6.71M |
| 5 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$4.48M |
Top Sells
| 1 |
Oracle
ORCL
|
+$1.6M |
| 2 |
Microsoft
MSFT
|
+$1.21M |
| 3 |
iShares Russell Top 200 Growth ETF
IWY
|
+$523K |
| 4 |
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
|
+$432K |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$431K |
Sector Composition
| 1 | Technology | 2.05% |
| 2 | Healthcare | 1.19% |
| 3 | Financials | 0.62% |
| 4 | Consumer Discretionary | 0.6% |
| 5 | Communication Services | 0.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GMDA
301
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $925 | ﹤0.01% |
25,629
| – | – |
|
302
ARK Innovation ETF
ARKK
$6.16B
| – | – |
-4,945
| Closed | -$259K |
|
303
Aspen Aerogels
ASPN
$425M
| – | – |
-12,123
| Closed | -$191K |
|
304
Algoma Steel
ASTL
$399M
| – | – |
-16,073
| Closed | -$161K |
|
305
Choice Hotels
CHH
$5.03B
| – | – |
-2,618
| Closed | -$297K |
|
|
OIO
306
OIO Group
OIO
$755M
| – | – |
-4,000
| Closed | -$8.35K |
|
307
SPDR Gold Trust
GLD
$129B
| – | – |
-1,061
| Closed | -$203K |
|
308
JetBlue
JBLU
$2.02B
| – | – |
-34,652
| Closed | -$192K |
|
309
PUT
NVIDIA
NVDA
$4.89T
| – | – |
-1,000
| Closed | -$10 |
|
310
Universal Display
OLED
$3.73B
| – | – |
-1,221
| Closed | -$234K |
|
|
311
PUT
Oracle
ORCL
$362B
| – | – |
-13,800
| Closed | -$889 |
|
312
Thermo Fisher Scientific
TMO
$198B
| – | – |
-395
| Closed | -$210K |
|
313
Union Pacific
UNP
$178B
| – | – |
-1,515
| Closed | -$372K |
|
314
PUT
ExxonMobil
XOM
$613B
| – | – |
-200
| Closed | -$1.31K |
|
Similar funds
VWM
NLGIA
IFA
DPCM
BOI
RAM
BHIA
WCMNY
McAdam LLC's Q1 2024 Portfolio in Review
As of Q1 2024, McAdam LLC held 315 positions worth $1.56B, up 12% from $1.39B the previous quarter. Its ten largest holdings account for 59% of the portfolio.
McAdam LLC deployed $80.8M of net new capital in Q1 2024, opening 35 new positions and adding to 144 existing holdings. Its largest new stake was JPMorgan Ultra-Short Income ETF: 20,001 shares worth $1.01M.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 2% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Oracle, an estimated $1.6M trimmed.
- McAdam LLC's largest Q1 2024 buy was JPMorgan Ultra-Short Income ETF: 20,001 shares worth $1.01M.
- McAdam LLC added most to Schwab US Large- Cap ETF in Q1 2024, an estimated $9.78M increase.
- McAdam LLC's biggest Q1 2024 reduction was Oracle, cutting an estimated $1.6M.
- McAdam LLC fully exited Union Pacific in Q1 2024, selling an estimated $372K.
- McAdam LLC's ten largest holdings make up 59% of its $1.56B portfolio in Q1 2024.
- McAdam LLC opened 35 new positions and closed 13 in Q1 2024.
- McAdam LLC's portfolio value rose 12% quarter-over-quarter to $1.56B.
Based on McAdam LLC's 13F filing for Q1 2024, filed 23 Apr 2024.